INSTANT STREAMING COURSE
Share:

Understanding and Implementing a Quality by Design (QbD) Program

This course equips pharmaceutical development professionals to apply Quality by Design principles in practical development environments, improving process understanding, risk-based decision making, and manufacturing consistency. It supports stronger alignment between product quality objectives, development rationale, and operational execution. This Course is designed for professionals involved in pharmaceutical development, process improvement, quality systems, and manufacturing consistency initiatives.

REGISTER FOR THE COURSE

US $190 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $190 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Steven Laurenz
  • Duration
    60 Minutes
  • Course ID
    TF2309
  • Ask the Expert
    Included
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

About the Course

Quality by Design has become an important approach for improving pharmaceutical development efficiency, product understanding, and manufacturing consistency. Effective implementation requires more than familiarity with terminology; it depends on the ability to connect development knowledge, process understanding, risk assessment, and control strategy into a practical operating model. Organizations often face challenges integrating these concepts across development functions, particularly when balancing innovation, process reliability, and product quality expectations.


This TalkFDA Live webinar explains the core principles behind a QbD approach and their application within pharmaceutical development organizations. The program addresses Quality Target Product Profile development, risk assessment methods, design space establishment, process analytical technology, and control planning. It also examines the use of models and design of experiments to support process understanding and decision-making throughout development and manufacturing activities.

  • Strengthen Development and Process Decision-Making:

    Participants will gain practical understanding of how QbD principles connect formulation knowledge, process understanding, and risk evaluation during pharmaceutical development. The course clarifies how tools such as design of experiments, modeling, and design space development support more informed technical decisions while reducing uncertainty during technology transfer and manufacturing scale-up activities.

  • Improve Manufacturing Consistency and Control Planning:

    The course explains how control strategies, FMEA practices, PAT applications, and operational profiles contribute to maintaining product quality throughout manufacturing. Organizations implementing QbD approaches are expected to demonstrate stronger process understanding and documented development rationale, making structured control planning increasingly important for product reliability and operational performance.

Key Areas Covered

  • Quality Target Product Profile (QTPP) development and its role in pharmaceutical product quality planning
  • Risk assessment approaches supporting development decisions and process understanding
  • Use of models and Design of Experiments to evaluate formulation and process variables
  • Establishing a development design space for manufacturing consistency and process control
  • Process Analytical Technology (PAT) applications within Quality by Design programs
  • FMEA, control plans, target operational profiles, and control strategy development

Who Must Attend

  • Quality Departments
  • Regulatory Departments
  • Compliance Departments
  • Production Departments
  • Manufacturing Departments
  • Engineering Departments
  • Process Owners
  • Quality Auditors
  • Development Departments

Quality training, expert insights, and answers that matter. Know your Expert

STEVEN LAURENZ

Steven Laurenz has more than 25 years of experience in pharmaceutical product development, process development, technology transfer, and manufacturing support. His background includes integrating Quality by Design and risk management principles into development organizations and establishing quality systems within R&D environments. He previously led product development departments at Abbott Laboratories and AbbVie Inc. and has held leadership roles in technical consortium activities related to pharmaceutical development and process improvement.

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How can a Quality by Design (QbD) program remain scientifically defensible when development knowledge changes over time?

Development knowledge is expected to evolve throughout a product lifecycle, but every significant change should be supported by documented scientific reasoning. Inspectors are less concerned that conclusions changed than they are with whether those changes can be explained and justified using objective evidence.


Scientific defensibility comes from maintaining a clear history of decisions. When process understanding improves, the supporting experiments, risk assessments, technical reviews, and approval records should show why earlier conclusions were revised and how the updated knowledge affected subsequent development activities.


Inspection friction often begins when teams cannot explain why a design space changed, why a critical process parameter was reclassified, or why acceptance criteria were modified. Missing decision history makes even technically sound changes appear arbitrary during regulatory review.


A mature QbD program preserves the evolution of knowledge instead of replacing older conclusions with new ones. That continuity demonstrates that development decisions were driven by evidence, creating stronger confidence in both the process and the supporting documentation.

What evidence demonstrates that Quality by Design has been implemented rather than documented?

Implementation is demonstrated when scientific knowledge consistently influences technical decisions, not simply when QbD terminology appears throughout development records. Reviewers look for evidence that process understanding shaped formulation, manufacturing, and control strategy decisions.


One of the strongest indicators is consistency across functions. Development reports, risk assessments, manufacturing documentation, analytical records, and regulatory submissions should all reflect the same scientific rationale without conflicting explanations or unsupported assumptions.


Inspection concerns increase when documentation exists but operational decisions cannot be traced back to development evidence. Teams sometimes complete required reports while making process changes that are disconnected from the original scientific justification, weakening the credibility of the overall program.


Well-executed QbD becomes visible through repeatable decision-making. Every important development choice should be supported by documented evidence that explains not only what was decided, but why that decision represented the most appropriate technical path.

How should organizations decide when additional development studies provide meaningful value instead of unnecessary complexity?

Additional studies should be performed only when they resolve an important scientific uncertainty that could influence product quality, manufacturing performance, or future development decisions. Generating more data is not valuable unless it answers a defined technical question.


Each proposed study should have a documented objective before work begins. If the results will not affect process design, control strategy, specifications, or risk evaluation, the study may increase workload without strengthening scientific understanding.


Inspection discussions often become difficult when large volumes of experimental data exist but their influence on final decisions cannot be demonstrated. Reviewers generally place greater confidence in focused investigations that clearly support technical conclusions.


Experienced development teams treat every study as evidence supporting a specific decision rather than an opportunity to collect additional information. This approach keeps development programs efficient while maintaining documentation that is easier to defend during regulatory review.

How should disagreements between cross-functional teams be resolved when they affect critical Quality by Design decisions?

Cross-functional disagreements should be resolved through documented scientific evidence rather than organizational influence. Differences between development, manufacturing, analytical, quality, and regulatory teams often reveal areas where additional evaluation or clarification is needed.


Structured governance helps ensure that competing viewpoints are evaluated consistently. Decision records should document the alternatives considered, the supporting evidence reviewed, the rationale for the selected approach, and any remaining uncertainties requiring future monitoring.


Inspection concerns increase when different departments provide conflicting explanations for the same development decision. Inconsistent records suggest weak knowledge management and make it difficult to demonstrate that technical conclusions were reached through a controlled process.


Well-managed discussions strengthen a QbD program because they produce transparent, evidence-based decisions. When disagreements are documented and resolved through objective evaluation, the resulting development history becomes more credible and easier to defend during regulatory assessments.

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can watch the course, access materials, and manage your learning.

3. Access course materials
The presentation handout and other materials can be downloaded inside the Course Player. You could use Discussion feature there to ask your questions.

4. Watch The Streaming and Complete your Course
The course playback will be available on the same course page. You could pause and continue or you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

The challenge with training is rarely signing up. It’s what happens afterward, when access, materials, & certification aren’t accessible from one place.
With TalkFDA Courses, Everything you need Live in One Place.
Simple. Organized. Professional.
Go ahead and Take the Course with confidence.

Our students love us ❤️

“Content was put together well. Didn’t feel like random slides. One thing actually led to the next.”

Manager, Quality Assurance
“Pacing was right. Didn’t feel dragged. Didn’t feel rushed either.”


Senior Manager, Operations
“Structure helped. Otherwise this topic can get messy quickly.”


Validation Specialist, QA

People who took this Course, also viewed